136 related articles for article (PubMed ID: 36179331)
1. Combination of Astrogliosis and Phosphorylated Tau for the Preclinical Diagnosis of Alzheimer Disease Using 3-Dimensional Stereotactic Surface Projection Images With 18 F-THK5351.
Imabayashi E; Saitoh Y; Tsukamoto T; Sakata M; Takano H
Clin Nucl Med; 2022 Dec; 47(12):1066-1068. PubMed ID: 36179331
[TBL] [Abstract][Full Text] [Related]
2. Correlations of
Harada R; Ishiki A; Kai H; Sato N; Furukawa K; Furumoto S; Tago T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Nakamura T; Yoshikawa T; Iwata R; Tashiro M; Sasano H; Kitamoto T; Yanai K; Arai H; Kudo Y; Okamura N
J Nucl Med; 2018 Apr; 59(4):671-674. PubMed ID: 28864633
[TBL] [Abstract][Full Text] [Related]
3. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
Nihashi T; Sakurai K; Kato T; Iwata K; Kimura Y; Ikenuma H; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Suzuki K; Bundo M; Sakurai T; Okamura N; Yanai K; Ito K; Nakamura A;
J Alzheimers Dis; 2022; 85(1):223-234. PubMed ID: 34776443
[TBL] [Abstract][Full Text] [Related]
5. Tau positron emission tomography using [
Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y
Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase B inhibitor, selegiline, reduces
Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
[TBL] [Abstract][Full Text] [Related]
7. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
8. MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer's Disease Model Mice.
Kang S; Kim J; Lee SY; Okamura N; Chang KA
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628296
[TBL] [Abstract][Full Text] [Related]
9. First-in-Humans Evaluation of
Villemagne VL; Harada R; Doré V; Furumoto S; Mulligan R; Kudo Y; Burnham S; Krishnadas N; Bozinovski S; Huang K; Lopresti BJ; Yanai K; Rowe CC; Okamura N
J Nucl Med; 2022 Oct; 63(10):1551-1559. PubMed ID: 35086898
[TBL] [Abstract][Full Text] [Related]
10. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
Kikuchi A; Okamura N; Hasegawa T; Harada R; Watanuki S; Funaki Y; Hiraoka K; Baba T; Sugeno N; Oshima R; Yoshida S; Kobayashi J; Ezura M; Kobayashi M; Tano O; Mugikura S; Iwata R; Ishiki A; Furukawa K; Arai H; Furumoto S; Tashiro M; Yanai K; Kudo Y; Takeda A; Aoki M
Neurology; 2016 Nov; 87(22):2309-2316. PubMed ID: 27794115
[TBL] [Abstract][Full Text] [Related]
11. [Imaging of neuropathology by PET tracers].
Harada R
Nihon Yakurigaku Zasshi; 2022; 157(6):453-457. PubMed ID: 36328560
[TBL] [Abstract][Full Text] [Related]
12. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
13. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
Ng KP; Therriault J; Kang MS; Struyfs H; Pascoal TA; Mathotaarachchi S; Shin M; Benedet AL; Massarweh G; Soucy JP; Rosa-Neto P; Gauthier S
Neuroimage Clin; 2019; 24():102091. PubMed ID: 31795034
[TBL] [Abstract][Full Text] [Related]
14. Head to head comparison of [
Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Evaluation of
Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
[TBL] [Abstract][Full Text] [Related]
16. 18F-THK5351 PET Can Identify Astrogliosis in Multiple Sclerosis Plaques.
Ishibashi K; Miura Y; Hirata K; Toyohara J; Ishii K
Clin Nucl Med; 2020 Feb; 45(2):e98-e100. PubMed ID: 31348091
[TBL] [Abstract][Full Text] [Related]
17. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
[TBL] [Abstract][Full Text] [Related]
18. Dual tracer tau PET imaging reveals different molecular targets for
Chiotis K; Stenkrona P; Almkvist O; Stepanov V; Ferreira D; Arakawa R; Takano A; Westman E; Varrone A; Okamura N; Shimada H; Higuchi M; Halldin C; Nordberg A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1605-1617. PubMed ID: 29752516
[TBL] [Abstract][Full Text] [Related]
19. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
Lockhart SN; Baker SL; Okamura N; Furukawa K; Ishiki A; Furumoto S; Tashiro M; Yanai K; Arai H; Kudo Y; Harada R; Tomita N; Hiraoka K; Watanuki S; Jagust WJ
PLoS One; 2016; 11(6):e0158460. PubMed ID: 27355840
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 3 Novel Tau Radiopharmaceuticals,
Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
